MORE►
Biote
Mary J. Puncochar
Biote Names Healthcare Veteran Chief Commercial Officer
by Lance Murray | May 31, 2023
Mary J. Puncochar will lead Biote’s commercial initiatives to expand its presence in the growing market for hormone replacement therapy. She brings more than 30 years' experience in sales, tech-enabled marketing, and management roles at leading healthcare, pharmaceutical, and medical device companies.
by Quincy Preston |
Apr 14, 2023
Irving-based Biote Corporation, a preventive healthcare solutions provider that delivers personalized hormone therapy, has appointed John Denne as general manager of its men’s health division. The move is aimed at expanding the company’s presence in the growing market for male hormone replacement therapy....
MORE►
by Dallas Innovates | Staff Report |
Dec 13, 2021
Irving-based Biote, a medical practice-building business within the hormone optimization space, will be listed on Nasdaq through a business combination with Haymaker Acquisition Corp. III.
Biote—which will earn projected revenue of $136 million in 2021—trains practitioners to identify and treat early indicators of hormone-related aging conditions. The company then provides components that enable practitioners to establish, build, and successfully operate hormone optimization centers.
Biote—which will earn projected revenue of $136 million in 2021—trains practitioners to identify and treat early indicators of hormone-related aging conditions. The company then provides components that enable practitioners to establish, build, and successfully operate hormone optimization centers.
MORE►
